LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED)
AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE
Approval overview LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED) is listed in Drugs@FDA under application 206006 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE Form and strength CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL - 500MG;500MG;30MG Sponsor RISING Submission history Latest submission status date: 2024-06-12 00:00:00.
Structured Monograph
Clinical summary
Approval overview LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED) is listed in Drugs@FDA under application 206006 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE Form and strength CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL - 500MG;500MG;30MG Sponsor RISING Submission history Latest submission status date: 2024-06-12 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.